• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据 POSEIDON 标准,秘鲁安第斯地区患者的累积活产率:一项单中心回顾性分析。

Cumulative live birth rates of patients in the Peruvian Andes according to the POSEIDON criteria: a single-center retrospective analysis.

机构信息

Centro de Fertilidad y Ginecología del Sur Cusco Peru Centro de Fertilidad y Ginecología del Sur, Cusco, Peru.

Centro de Fertilidad y Ginecología del Sur, Cusco, Peru.

出版信息

JBRA Assist Reprod. 2021 Jul 21;25(3):412-416. doi: 10.5935/1518-0557.20200107.

DOI:10.5935/1518-0557.20200107
PMID:33739802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8312301/
Abstract

OBJECTIVE

To identify low prognosis in-vitro fertilization (IVF) patients treated at Centro de Fertilidad y Ginecología del Sur (CFGS) based on the POSEIDON criteria.

METHODS

This retrospective study included 412 IVF patients and assessed them based on the POSEIDON criteria to describe the cumulative live birth rates seen in each group.

RESULTS

13.1% of patients met the POSEIDON criteria, and the proportion of cases in POSEIDON groups 1, 2, 3 and 4 were 20.4%, 31.5%, 14.8%, and 33.3%, respectively. The cumulative live birth rate for the individuals meeting the POSEIDON criteria was 25.9%, while for patients in POSEIDON groups 1, 2, 3, and 4 the rates were 45.5%, 29.4%, 25.0%, and 11%, respectively. The differences were not statistically significant due to the small number of cases.

CONCLUSIONS

Patients belonging to the four POSEIDON groups were described at CFGS. Age and number of retrieved mature oocytes were determining parameters in the prognosis of pregnancy in IVF/ICSI patients.

摘要

目的

根据 POSEIDON 标准,识别在南方生育与妇科中心(CFGS)接受治疗的低预后体外受精(IVF)患者。

方法

这项回顾性研究纳入了 412 名 IVF 患者,并根据 POSEIDON 标准对其进行评估,以描述每个组别的累积活产率。

结果

13.1%的患者符合 POSEIDON 标准,POSEIDON 组 1、2、3 和 4 的病例比例分别为 20.4%、31.5%、14.8%和 33.3%。符合 POSEIDON 标准的患者的累积活产率为 25.9%,而 POSEIDON 组 1、2、3 和 4 的患者的活产率分别为 45.5%、29.4%、25.0%和 11%。由于病例数量较少,差异无统计学意义。

结论

在 CFGS 描述了属于四个 POSEIDON 组的患者。年龄和可获取的成熟卵母细胞数量是 IVF/ICSI 患者妊娠预后的决定因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d68/8312301/1d8af573d46a/jbra-25-03-0412-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d68/8312301/1d8af573d46a/jbra-25-03-0412-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d68/8312301/1d8af573d46a/jbra-25-03-0412-g01.jpg

相似文献

1
Cumulative live birth rates of patients in the Peruvian Andes according to the POSEIDON criteria: a single-center retrospective analysis.根据 POSEIDON 标准,秘鲁安第斯地区患者的累积活产率:一项单中心回顾性分析。
JBRA Assist Reprod. 2021 Jul 21;25(3):412-416. doi: 10.5935/1518-0557.20200107.
2
Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.孕激素预处理卵巢刺激与灵活 GnRH 拮抗剂方案在低预后患者中累积活产率的比较。
Front Endocrinol (Lausanne). 2021 Sep 13;12:705264. doi: 10.3389/fendo.2021.705264. eCollection 2021.
3
Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.POSEIDON 患者每周期抽吸 IVF/ICSI 的累积妊娠率:9073 例真实世界证据研究。
Hum Reprod. 2021 Jul 19;36(8):2157-2169. doi: 10.1093/humrep/deab152.
4
Cumulative live birth rates and birth outcomes after IVF/ICSI treatment cycles in young POSEIDON patients: A real-world study.年轻 POSEIDON 患者接受 IVF/ICSI 治疗周期后的累积活产率和出生结局:一项真实世界研究。
Front Endocrinol (Lausanne). 2023 Mar 30;14:1107406. doi: 10.3389/fendo.2023.1107406. eCollection 2023.
5
Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.根据 POSEIDON 标准,低预后患者中 GnRH-A 与 PPOS 累积活产率的比较:一项队列研究。
Front Endocrinol (Lausanne). 2021 Jun 21;12:644456. doi: 10.3389/fendo.2021.644456. eCollection 2021.
6
Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria.根据 POSEIDON 标准对低预后患者进行生长激素联合治疗。
Front Endocrinol (Lausanne). 2021 Dec 2;12:790160. doi: 10.3389/fendo.2021.790160. eCollection 2021.
7
Cumulative live birth rates in low-prognosis women.低预后女性的累积活产率。
Hum Reprod. 2019 Jun 4;34(6):1030-1041. doi: 10.1093/humrep/dez051.
8
Cumulative live birth rate of low prognosis patients with POSEIDON stratification: a single-centre data analysis.POSEIDON 分层低预后患者的累积活产率:单中心数据分析。
Reprod Biomed Online. 2020 Nov;41(5):834-844. doi: 10.1016/j.rbmo.2020.08.003. Epub 2020 Aug 10.
9
Cumulative live-birth, perinatal and obstetric outcomes for POSEIDON groups after IVF/ICSI cycles: a single-center retrospective study.POSEIDON 分组后 IVF/ICSI 周期的累积活产、围产儿和产科结局:一项单中心回顾性研究。
Sci Rep. 2020 Jul 16;10(1):11822. doi: 10.1038/s41598-020-68896-1.
10
Live birth rates of low prognosis patients according to POSEIDON criteria; A retrospective cohort study.根据 POSEIDON 标准,低预后患者的活产率:一项回顾性队列研究。
J Gynecol Obstet Hum Reprod. 2020 Sep;49(7):101817. doi: 10.1016/j.jogoh.2020.101817. Epub 2020 May 16.

引用本文的文献

1
Comparison of Cumulative Live Birth Rate (CLBR) According to Patient Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) Stratification Among Low Prognosis Women Undergoing IVF-ICSI Cycles.体外受精-卵胞浆内单精子注射(IVF-ICSI)周期中低预后女性根据包含个体化卵母细胞数量的以患者为导向策略(POSEIDON)分层的累积活产率(CLBR)比较。
J Reprod Infertil. 2023 Apr-Jun;24(2):117-131. doi: 10.18502/jri.v24i2.12497.

本文引用的文献

1
Live birth rates of low prognosis patients according to POSEIDON criteria; A retrospective cohort study.根据 POSEIDON 标准,低预后患者的活产率:一项回顾性队列研究。
J Gynecol Obstet Hum Reprod. 2020 Sep;49(7):101817. doi: 10.1016/j.jogoh.2020.101817. Epub 2020 May 16.
2
Novel Physiology and Definition of Poor Ovarian Response; Clinical Recommendations.卵巢反应不良的新生理学和定义;临床建议。
Int J Mol Sci. 2020 Mar 19;21(6):2110. doi: 10.3390/ijms21062110.
3
Commentary: Management Strategies for POSEIDON Groups 3 and 4.评论:POSEIDON 3组和4组的管理策略
Front Endocrinol (Lausanne). 2020 Jan 24;10:920. doi: 10.3389/fendo.2019.00920. eCollection 2019.
4
The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists.从临床医生和胚胎学家的视角看POSEIDON标准及其成功衡量指标
Front Endocrinol (Lausanne). 2019 Nov 20;10:814. doi: 10.3389/fendo.2019.00814. eCollection 2019.
5
Cumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of Fertilization/Intracytoplasmic Sperm Injection.根据波塞冬标准的低预后患者累积活产率:对26697个受精/卵胞浆内单精子注射周期的分析
Front Endocrinol (Lausanne). 2019 Sep 19;10:642. doi: 10.3389/fendo.2019.00642. eCollection 2019.
6
Cumulative Live Birth Rates of Good and Low Prognosis Patients According to POSEIDON Criteria: A Single Center Analysis of 18,455 Treatment Cycles.根据波塞冬标准的良好和低预后患者的累积活产率:18455个治疗周期的单中心分析
Front Endocrinol (Lausanne). 2019 Jun 26;10:409. doi: 10.3389/fendo.2019.00409. eCollection 2019.
7
An Observational Retrospective Cohort Trial on 4,828 IVF Cycles Evaluating Different Low Prognosis Patients Following the POSEIDON Criteria.一项针对4828个体外受精周期的观察性回顾性队列试验,根据POSEIDON标准评估不同低预后患者。
Front Endocrinol (Lausanne). 2019 May 8;10:282. doi: 10.3389/fendo.2019.00282. eCollection 2019.
8
Cumulative live birth rates in low-prognosis women.低预后女性的累积活产率。
Hum Reprod. 2019 Jun 4;34(6):1030-1041. doi: 10.1093/humrep/dez051.
9
Estimation of age-dependent decrease in blastocyst euploidy by next generation sequencing: development of a novel prediction model.通过下一代测序估计胚胎囊胚非整倍体率随年龄的下降:一种新预测模型的建立。
Panminerva Med. 2019 Mar;61(1):3-10. doi: 10.23736/S0031-0808.18.03507-3. Epub 2018 Jun 28.
10
The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome.辅助生殖技术中“低预后患者”的新型波塞冬分层及其成功结局的提议标志物。
F1000Res. 2016 Dec 23;5:2911. doi: 10.12688/f1000research.10382.1. eCollection 2016.